Cannara Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 21, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Market Cap	187	164	61	90	118	149
Market Cap Growth	17.35%	167.19%	-32.22%	-23.72%	-20.54%	112.60%
Enterprise Value	201.89	190.78	102.92	131.82	154.67	161.74
Last Close Price	1.84	1.80	0.68	1.00	1.35	1.70
PE Ratio	17.19	12.86	9.71	12.50	45.00	-
Forward PE	10.36	12.41	-	-	-	-
PS Ratio	1.59	1.52	0.75	1.57	3.29	8.63
PB Ratio	1.48	1.60	0.70	1.13	1.77	2.32
P/TBV Ratio	1.45	1.63	0.71	1.13	1.78	2.03
P/FCF Ratio	32.79	11.98	19.05	-	-	-
P/OCF Ratio	9.61	8.17	5.73	15.28	-	-
EV/Sales Ratio	1.72	1.78	1.25	2.29	4.30	9.37
EV/EBITDA Ratio	8.08	6.61	6.26	7.83	17.45	49.26
EV/EBIT Ratio	11.06	8.60	10.21	11.09	31.31	628.63
EV/FCF Ratio	35.46	13.97	32.02	-	-	-
Debt / Equity Ratio	0.27	0.34	0.51	0.54	0.69	0.32
Debt / EBITDA Ratio	1.46	1.44	2.94	2.72	5.46	6.36
Debt / FCF Ratio	6.50	3.05	15.04	-	-	-
Net Debt / Equity Ratio	0.12	0.27	0.47	0.52	0.54	0.20
Net Debt / EBITDA Ratio	0.60	0.94	2.54	2.47	4.09	3.88
Net Debt / FCF Ratio	2.67	1.99	12.98	-10.46	-1.68	-0.38
Asset Turnover	0.64	0.66	0.55	0.43	0.33	0.38
Inventory Turnover	1.25	1.32	1.41	1.38	1.66	2.30
Quick Ratio	1.24	0.83	0.73	0.70	1.75	1.64
Current Ratio	3.00	2.40	2.50	2.44	3.46	2.82
Return on Equity (ROE)	9.16%	13.75%	7.68%	9.48%	3.52%	-4.77%
Return on Assets (ROA)	6.76%	9.92%	9.77%	8.90%	4.54%	0.56%
Return on Invested Capital (ROIC)	9.10%	12.38%	11.54%	10.60%	5.49%	0.34%
Return on Capital Employed (ROCE)	12.27%	16.93%	8.13%	10.16%	4.97%	0.60%
Earnings Yield	5.82%	7.78%	10.29%	8.00%	2.22%	-
FCF Yield	3.05%	8.35%	5.25%	-	-	-
Buyback Yield / Dilution	-5.67%	-1.08%	-1.83%	-2.16%	-14.80%	-3.72%
Total Shareholder Return	-5.67%	-1.08%	-1.83%	-2.16%	-14.80%	-3.72%

Cannara Biotech Ratios and Metrics Data Source

Cannara Biotech Ratios and Metrics